相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GAMMA: a tool for the rapid identification, classification and annotation of translated gene matches from sequencing data
Richard A. Stanton et al.
BIOINFORMATICS (2022)
Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019
Ian Kracalik et al.
EMERGING INFECTIOUS DISEASES (2022)
National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017
Jannette Pirzadian et al.
SCIENTIFIC REPORTS (2021)
Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection
Rachel Wheatley et al.
NATURE COMMUNICATIONS (2021)
Variability of Beta-Lactam Broth Microdilution for Pseudomonas aeruginosa
A. A. Bhalodi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Reversing Antibiotic Resistance Caused by Mobile Resistance Genes of High Fitness Cost
Jinyong Wu et al.
MSPHERE (2021)
Synthesis of Catechin-Rare Earth Complex with Efficient and Broad-Spectrum Anti-Biofilm Activity
Lu Liu et al.
CHEMISTRY & BIODIVERSITY (2020)
ResFinder 4.0 for predictions of phenotypes from genotypes
Valeria Bortolaia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Development and Application of a Core Genome Multilocus Sequence Typing Scheme for the Health Care-Associated Pathogen Pseudomonas aeruginosa
Richard A. Stanton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Characterization of a SPM-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa by comparative genomics and phenotypic analysis
Ana Paula Barbosa do Nascimento et al.
SCIENTIFIC REPORTS (2020)
Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update
Ester del Barrio-Tofino et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Comparative genomics of ocular Pseudomonas aeruginosa strains from keratitis patients with different clinical outcomes
Kathirvel Kandasamy et al.
GENOMICS (2020)
Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016
Dee Shortridge et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days
Leif Tueffers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates
Michael Feldgarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Large-scale identification of pathogen essential genes during coinfection with sympatric and allopatric microbes
Gina R. Lewin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Systems-level analysis of NalD mutation, a recurrent driver of rapid drug resistance in acute Pseudomonas aeruginosa infection
Jinyuan Yan et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany
Elena Schaefer et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
Maroya Spalding Walters et al.
EMERGING INFECTIOUS DISEASES (2019)
Detection of carbapenemase-producing Pseudomonas aeruginosa by phenotypic and genotypic methods in a tertiary care hospital of East India
Nishu Verma et al.
JOURNAL OF LABORATORY PHYSICIANS (2019)
KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany
Juergen Benjamin Hagemann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Multi-drug resistant Pseudomonas aeruginosa nosocomial strains: Molecular epidemiology and evolution
Silvia Angeletti et al.
MICROBIAL PATHOGENESIS (2018)
Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam
Fernando Sanz-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
Dinesh Subedi et al.
PLOS ONE (2018)
Comparison of five commonly used automated susceptibility testing methods for accuracy in the China Antimicrobial Resistance Surveillance System (CARSS) hospitals
Menglan Zhou et al.
INFECTION AND DRUG RESISTANCE (2018)
Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital
Alma Lopez-Garcia et al.
INFECTION AND DRUG RESISTANCE (2018)
Large Cluster of Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Isolates Colonizing Residents at a Skilled Nursing Facility - Chicago, Illinois, November 2016-March 2018
Whitney J. Clegg et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Functional Mechanism of the Efflux Pumps Transcription Regulators From Pseudomonas aeruginosa Based on 3D Structures
Karim Housseini B. Issa et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis
S. Stefani et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa
Peter Jorth et al.
MBIO (2017)
Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395
Marie Petitjean et al.
MICROBIAL GENOMICS (2017)
Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation
Nuala A. O'Leary et al.
NUCLEIC ACIDS RESEARCH (2016)
Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data
Veronica N. Kos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa
Ya-ping Pan et al.
ARCHIVES OF MICROBIOLOGY (2016)
Antimicrobial Resistance Prediction in PATRIC and RAST
James J. Davis et al.
SCIENTIFIC REPORTS (2016)
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains
John J. Varga et al.
BMC GENOMICS (2015)
The increasing threat of Pseudomonas aeruginosa high-risk clones
Antonio Oliver et al.
DRUG RESISTANCE UPDATES (2015)
In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure
Mar Sole et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes
Sushim Kumar Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Dilip Nathwani et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2014)
Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review
Ana Margarida Sousa et al.
PATHOGENS (2014)
Acquired Class D β-Lactamases
Nuno T. Antunes et al.
ANTIBIOTICS-BASEL (2014)
Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies
Hui Li et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
AmpG Inactivation Restores Susceptibility of Pan-β-Lactam-Resistant Pseudomonas aeruginosa Clinical Strains
Laura Zamorano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Role of the MexEF-OprN Efflux System in Low-Level Resistance of Pseudomonas aeruginosa to Ciprofloxacin
Catherine Llanes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime
A. B. Campo Esquisabel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a Significant Role in Death Due to Lung Infection
Jeevan Jyot et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Maria Tomas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparison of BD Phoenix, Vitek 2, and MicroScan Automated Systems for Detection and Inference of Mechanisms Responsible for Carbapenem Resistance in Enterobacteriaceae
Neil Woodford et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance
Cecilia Andresen et al.
PROTEIN SCIENCE (2010)
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Philip D. Lister et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa
D Girlich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Mutations affecting DNA-binding activity of the MexR repressor of mexR-mexA-mexB-oprM operon expression
K Saito et al.
JOURNAL OF BACTERIOLOGY (2003)
The MexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa:: Characterization of mutations compromising activity
L Adewoye et al.
JOURNAL OF BACTERIOLOGY (2002)
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover et al.
NATURE (2000)
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
A Oliver et al.
SCIENCE (2000)
分享论文
